The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Anti-fungal Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair and nails.
The global Anti-fungal Drugs market size is expected to reach US$ 2097.9 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Anti-fungal Drugs in various end use industries. The expanding demands from the Hospital, Retail Pharmacy and Online Pharmacy,, are propelling Anti-fungal Drugs market. Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ointment segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-fungal Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti-fungal Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti-fungal Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-fungal Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti-fungal Drugs covered in this report include Abbott Laboratories, Astellas Pharma, Bayer, GlaxoSmithKline, Glenmark, Kramer Laboratories, Merck, Novartis and Pfizer, etc.
The global Anti-fungal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Astellas Pharma
Bayer
GlaxoSmithKline
Glenmark
Kramer Laboratories
Merck
Novartis
Pfizer
SCYNEXIS
Sanofi
Gilead Science
Enzon Pharmaceuticals
Global Anti-fungal Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-fungal Drugs market, Segment by Type:
Powder
Ointment
Tablet
Other
Global Anti-fungal Drugs market, by Application
Hospital
Retail Pharmacy
Online Pharmacy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Anti-fungal Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair and nails.
The global Anti-fungal Drugs market size is expected to reach US$ 2097.9 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Anti-fungal Drugs in various end use industries. The expanding demands from the Hospital, Retail Pharmacy and Online Pharmacy,, are propelling Anti-fungal Drugs market. Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ointment segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-fungal Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti-fungal Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti-fungal Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-fungal Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti-fungal Drugs covered in this report include Abbott Laboratories, Astellas Pharma, Bayer, GlaxoSmithKline, Glenmark, Kramer Laboratories, Merck, Novartis and Pfizer, etc.
The global Anti-fungal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Astellas Pharma
Bayer
GlaxoSmithKline
Glenmark
Kramer Laboratories
Merck
Novartis
Pfizer
SCYNEXIS
Sanofi
Gilead Science
Enzon Pharmaceuticals
Global Anti-fungal Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-fungal Drugs market, Segment by Type:
Powder
Ointment
Tablet
Other
Global Anti-fungal Drugs market, by Application
Hospital
Retail Pharmacy
Online Pharmacy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Anti-fungal Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Anti-fungal Drugs
1.1 Anti-fungal Drugs Market Overview
1.1.1 Anti-fungal Drugs Product Scope
1.1.2 Anti-fungal Drugs Market Status and Outlook
1.2 Global Anti-fungal Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Anti-fungal Drugs Market Size by Region (2018-2029)
1.4 Global Anti-fungal Drugs Historic Market Size by Region (2018-2023)
1.5 Global Anti-fungal Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Anti-fungal Drugs Market Size (2018-2029)
1.6.1 North America Anti-fungal Drugs Market Size (2018-2029)
1.6.2 Europe Anti-fungal Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Anti-fungal Drugs Market Size (2018-2029)
1.6.4 Latin America Anti-fungal Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Anti-fungal Drugs Market Size (2018-2029)
2 Anti-fungal Drugs Market by Type
2.1 Introduction
2.1.1 Powder
2.1.2 Ointment
2.1.3 Tablet
2.1.4 Other
2.2 Global Anti-fungal Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Anti-fungal Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Anti-fungal Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Anti-fungal Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Anti-fungal Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Anti-fungal Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Anti-fungal Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Anti-fungal Drugs Revenue Breakdown by Type (2018-2029)
3 Anti-fungal Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Retail Pharmacy
3.1.3 Online Pharmacy
3.2 Global Anti-fungal Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Anti-fungal Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Anti-fungal Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Anti-fungal Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Anti-fungal Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Anti-fungal Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Anti-fungal Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Anti-fungal Drugs Revenue Breakdown by Application (2018-2029)
4 Anti-fungal Drugs Competition Analysis by Players
4.1 Global Anti-fungal Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-fungal Drugs as of 2022)
4.3 Date of Key Players Enter into Anti-fungal Drugs Market
4.4 Global Top Players Anti-fungal Drugs Headquarters and Area Served
4.5 Key Players Anti-fungal Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Anti-fungal Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Anti-fungal Drugs Products, Services and Solutions
5.1.4 Abbott Laboratories Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Astellas Pharma
5.2.1 Astellas Pharma Profile
5.2.2 Astellas Pharma Main Business
5.2.3 Astellas Pharma Anti-fungal Drugs Products, Services and Solutions
5.2.4 Astellas Pharma Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Astellas Pharma Recent Developments
5.3 Bayer
5.3.1 Bayer Profile
5.3.2 Bayer Main Business
5.3.3 Bayer Anti-fungal Drugs Products, Services and Solutions
5.3.4 Bayer Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 GlaxoSmithKline Recent Developments
5.4 GlaxoSmithKline
5.4.1 GlaxoSmithKline Profile
5.4.2 GlaxoSmithKline Main Business
5.4.3 GlaxoSmithKline Anti-fungal Drugs Products, Services and Solutions
5.4.4 GlaxoSmithKline Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 GlaxoSmithKline Recent Developments
5.5 Glenmark
5.5.1 Glenmark Profile
5.5.2 Glenmark Main Business
5.5.3 Glenmark Anti-fungal Drugs Products, Services and Solutions
5.5.4 Glenmark Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Glenmark Recent Developments
5.6 Kramer Laboratories
5.6.1 Kramer Laboratories Profile
5.6.2 Kramer Laboratories Main Business
5.6.3 Kramer Laboratories Anti-fungal Drugs Products, Services and Solutions
5.6.4 Kramer Laboratories Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Kramer Laboratories Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Anti-fungal Drugs Products, Services and Solutions
5.7.4 Merck Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Anti-fungal Drugs Products, Services and Solutions
5.8.4 Novartis Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Anti-fungal Drugs Products, Services and Solutions
5.9.4 Pfizer Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Pfizer Recent Developments
5.10 SCYNEXIS
5.10.1 SCYNEXIS Profile
5.10.2 SCYNEXIS Main Business
5.10.3 SCYNEXIS Anti-fungal Drugs Products, Services and Solutions
5.10.4 SCYNEXIS Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 SCYNEXIS Recent Developments
5.11 Sanofi
5.11.1 Sanofi Profile
5.11.2 Sanofi Main Business
5.11.3 Sanofi Anti-fungal Drugs Products, Services and Solutions
5.11.4 Sanofi Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.11.5 Sanofi Recent Developments
5.12 Gilead Science
5.12.1 Gilead Science Profile
5.12.2 Gilead Science Main Business
5.12.3 Gilead Science Anti-fungal Drugs Products, Services and Solutions
5.12.4 Gilead Science Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.12.5 Gilead Science Recent Developments
5.13 Enzon Pharmaceuticals
5.13.1 Enzon Pharmaceuticals Profile
5.13.2 Enzon Pharmaceuticals Main Business
5.13.3 Enzon Pharmaceuticals Anti-fungal Drugs Products, Services and Solutions
5.13.4 Enzon Pharmaceuticals Anti-fungal Drugs Revenue (US$ Million) & (2018-2023)
5.13.5 Enzon Pharmaceuticals Recent Developments
6 North America
6.1 North America Anti-fungal Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Anti-fungal Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Anti-fungal Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Anti-fungal Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Anti-fungal Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Anti-fungal Drugs Market Dynamics
11.1 Anti-fungal Drugs Industry Trends
11.2 Anti-fungal Drugs Market Drivers
11.3 Anti-fungal Drugs Market Challenges
11.4 Anti-fungal Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
